SCHEMBL24064802

SCHEMBL24064802

c1ccc([Si](c2ccccc2)(c2ccccc2)c2cccc(-n3c4ccccc4c4cc(-c5cccc(-n6c7ccccc7c7ccccc76)c5)ccc43)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TSPO P30536 2/20 0.36
PTGER4 P35408 1/20 0.35
NPY5R Q15761 2/20 0.34
KMT2A Q03164 3/20 0.34
IL1R1 P14778 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
HTT P42858 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.33
PDE10A Q9Y233 1/20 0.33
RAC2 P15153 1/20 0.33
RAC3 P60763 1/20 0.33
CDC42 P60953 1/20 0.33
RAC1 P63000 1/20 0.33
FAAH O00519 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21883222 0.99 ATM (0.45) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL18779576 0.99 ATM (0.45) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL18805014 0.99 ATM (0.45) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL17228095 0.97 L3MBTL1 (0.49) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL18779566 0.96 L3MBTL1 (0.49) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL18779599 0.96 ATM (0.45) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL24064809 0.96 L3MBTL1 (0.49) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL18805008 0.96 ATM (0.45) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL17832052 0.96 L3MBTL1 (0.51) L3MBTL1ATMKDM4ETSPOPTGER4
SCHEMBL21883379 0.95 ATM (0.41) L3MBTL1ATMKDM4ETSPOPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230129565-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20230129565-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20210376262-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376262-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE AR, ARL1, CRY1 L3MBTL1 2443/4885ATM 1616/4885KDM4E 2511/4885
US-20230129565-A1 ORGANIC ELECTROLUMINESCENCE DEVICE MAL2, SLC39A14, SLC39A3 L3MBTL1 432/4885ATM 4245/4885KDM4E 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.